:::

詳目顯示

回上一頁
題名:以Risperidone增強Fluvoxamine對難治型強迫症的治療效果:一例報告
書刊名:臺灣精神醫學
作者:蘇聖棻湯華盛 引用關係蔡長哲藍先元陳喬琪胡維恆
作者(外文):Su, Sheng-fenTang, Hwa-shengTsai, Chang-jerLane, Hsien-yuanChen, Chiao-chicyHu, Wei-herng
出版日期:1999
卷期:13:4
頁次:頁87-93
主題關鍵詞:增強難治型強迫症RisperidoneFluvoxamineAugmentationRefractoryObsessive-compulsive disorder
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(1) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:61
     目的:報告一例難治型強迫症患的治療過程並回顧文獻,討論難治型強迫症患者 的藥物治療對策。病例報告:一位21歲女性強迫症患者,二年前開始出現強迫症狀,最近 十個月以來症狀加劇,曾至多家醫院求診,對於fluoxetine, fluvoxamine或 fluvoxamine 併用sulpiride療效不佳,後來服用fluvoxamine併用低劑量risperidone約一個月後,強迫 症狀大幅改善。結論:治療難治型強迫症患者,可考慮併用低劑量risperidone,增強血清 素再吸收抑制劑(serotonin reuptake inhibitors, SRIs)的治療效果。 
     To report a case of refractory obsessive-compulsive disorder and discuss risperidone augmentation of fluvoxamine therapy in such case. Case Report: A 21 year-old woman with a diagnosis of obsessive-compulsive disorder had a two-year history of obsessive-compulsive symptoms. Her symptoms had become exacerbated in the ten months prior to admission, and she had sought help at several hospitals for help. Fluoxetine, fluxoxamine, or fluvoxamine combined with sulpiride had been prescribed but in vain. Low dosage of risperidone augmentation of fluvoxamine resulted in significant improvement of her symptoms one month later. Conclusion: Low dosage of risperidone augmenation reduces obsessive-compulsive symptoms in patients with refractory obsessive-compulsive disorder. (Full Text in Chinese)
期刊論文
1.Robins, L. N.、Helzer, J. E.、Weissman, M. M.(1984)。Lifetime prevalence of specific psychiatric disorders in three sites。Arch. General Psychiatry,41,949-958。  new window
2.Montgomery, S. A.(1999)。Treatment of obessive-compulsive disorder。CNS Spectrum,5(suppl.3),46-50。  new window
3.Zohar, J.、Insel, T. R.(1987)。Obsessive-compulsive disorder: psychological approaches to diagnosis, treatment and pathophysiology。Biol Psychiatry,22,667-687。  new window
4.McDougle, C. J.、Goodman, W. K.、Leckman, J. F.(1993)。The psychopharmacology of obsessive compulsive disorder: implications for treatment and pathogenesis。Psychiatr Clin North Am,16,749-766。  new window
5.Saxena, S.、Wang, D.、Bystritsky, A.、Baxter, L. R.(1996)。Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder。J Clin Psychiatry,57,303-306。  new window
6.McDougle, C. J.(1997)。Update on pharmacologic management of OCD: Agents and augmentation。J Clin Psychiatry,58,11-17。  new window
7.Goodman, W. K.、Price, L. H.、Rasmussen, S. A.(1989)。The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability, II: validity。Arch Gen Psychiatry,46,1006-1016。  new window
8.Insel, T. R.、Mueller, E. A.、Altrerman, I.(1985)。Obsessive -compulsive disorder and serotonin: Is there a connection?。Biol Psychiatry,20,1174-1180。  new window
9.Goodman, W. K.、McDougle, C. J.、Price, L. H.(1990)。Beyond the serotonin hypothesis: a role for dopamine in some form of OCD?。J Clin Psychiatry,51,36-43。  new window
10.Austin, L. S.、Lydiard, B.、Ballenger, J. C.(1991)。Dopamine blocking activity of clomipramine in patients with OCD。Biol Psychiatry,30,225-232。  new window
11.Lipinski, J. F.、Mallya, G.、Zimmerman, P.(1989)。Fluoxetine induced akathisia: clinical and theoretical implications。J Clin Psychiatry,50,339-342。  new window
12.Insel, T. R.(1992)。Toward a neuroanatomy of OCD。Arch Gen Psychiatry,49,739-744。  new window
13.Remington, G.、Kapur, S.(1999)。D2 and 5-HT2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET。J Clin Psychiatry,60,15-19。  new window
14.McDougle, C. J.、Goodman, W. K.、Price, L. H.(1990)。Neuroleptic addition in fluvoxamine-refractor obsessive -compulsive disorder。Am J Psychiatry,147,652-654。  new window
15.Kapur, S.、Remington, G.(1996)。Serotonin-dopamine interaction and its relevance to schizophrenia。Am J Psychiatry,153,466-476。  new window
16.Westphal, K.(1878)。Ueber Zwangsvorstellungen。Archiv Fur Psychiatr und Nervenkr,8,734-750。  new window
17.Fenton, W. S.、McGlashan, T. H.(1986)。The prognostic significance of obsessive-compulsive symptoms in schizophrenia。Am J Psychiatry,143,437-441。  new window
18.Caley, C. F.、Weber, S. S.(1995)。Sulpiride: an antipsychotic with selective dopaminergic antagonist properties。Ann Pharmacother,29,152-160。  new window
19.Mahendran, R.(1999)。Obsessive-compulsive symptoms with risperidone。J Clin Psychiatry,60,261-263。  new window
20.Dodt, J. E.、Byerly, M. J.、Cuadros, C.(1997)。Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline。Am J Psychiatry,154,582。  new window
圖書
1.American Psychiatry Association(1994)。Diagnostic and Statistical Manual of Mental Disorders。Washington, DC:American Psychiatric Association。  new window
2.Pfohl, B.、Blum, N.、Zimmerman, M.、Stangl, D.(1989)。The Structured Interview for DSM-III-R Personality。University of Iowa, Department of Psychiatry。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE